Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.77
Bid: 9.74
Ask: 10.20
Change: 0.00 (0.00%)
Spread: 0.46 (4.723%)
Open: 9.77
High: 0.00
Low: 0.00
Prev. Close: 9.77
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1 Issuance for a total nominal amount

9 Nov 2017 07:00

RNS Number : 9890V
Banco Bilbao Vizcaya Argentaria SA
08 November 2017
 

 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, and further to the relevant information dated 7th November 2017, hereby proceeds to notify the following:

 

 

RELEVANT INFORMATION

 

 

 

BBVA has agreed to carry out an issue of preferred securities contingently convertible into newly issued ordinary shares of BBVA with exclusion of pre-emptive subscription rights for shareholders (the "Securities") for a total nominal amount of 1,000,000,000 US Dollars (the "Issuance").

 

The remuneration of the Securities, whose payment is subject to certain conditions and to the discretion of the Bank, has been set at 6.125% on an annual basis for the first ten years. After that, it will be reviewed in accordance with the applicable terms and conditions of the Issuance by applying a margin of 387 basis points on the 5-year Mid-Swap Rate.

 

BBVA will request that the Securities qualify as Additional Tier 1 Capital pursuant to Law 10/2014, of 26 June, on regulation, supervision and solvency of credit entities and Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013, on prudential requirements for credit institutions and investment firms.

 

The Securities shall not be offered, distributed or sold in Spain or to Spanish tax residents, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

BBVA will request the listing of the Securities on the Global Exchange Market of the Irish Stock Exchange plc.

 

Furthermore, BBVA informs that, for the purposes set out in articles 414, 417 and 511 of the Corporate Enterprises Act, the director's report and the report of the independent expert/auditor of accounts different from BBVA's auditor, both related to the Issuance, have been issued. These reports will be available to shareholders through their publication on BBVA's website (www.bbva.com) on the Issuance closing date (expected to take place on 16th November 2017) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

 

 

Madrid, 8 November 2017

 

 

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Japan, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States and the Securities may not be offered or sold in the United States nor to, on behalf or for the benefit of, any citizen of the United States, as defined in the Regulation S of the US Securities Act of 1933, as amended ("US Securities Act"), unless such Issuance is registered or falls under an exception of registration pursuant the US Securities Act.

In relation with the Issuance, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Issuance. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus but rather is an announcement, and investors should not subscribe for any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFFPESXXFAF
Date   Source Headline
1st Aug 202210:11 amRNSShares buyback program 010822
29th Jul 20227:00 amRNS2Q22 Results Presentation
29th Jul 20227:00 amRNS2Q22 Results Report
29th Jul 20227:00 amRNS2Q22 Results Press Release
22nd Jul 202210:18 amRNS220722_BBVA_SBB Follow up Reporting
20th Jul 20224:56 pmRNS2Q22 Results Presentation Announcement
15th Jul 202210:11 amRNSBBVA_ Shares Buyback_Follow up Reporting
8th Jul 202210:14 amRNS220708_BBVA_SBB Follow up Reporting
8th Jul 20228:10 amRNS20220708 OIR Public Sector Bonds
8th Jul 20228:10 amRNS20220708 BBVA - OIR Mortgage Bonds
29th Jun 20228:13 amRNSBuy Back Program - Terms and Conditions 2º Segment
29th Jun 20227:00 amRNSImplementation of IAS 29 to BBVA Turkey
29th Jun 20227:00 amRNSBuy Back Program - Second Segment
16th Jun 20227:00 amRNSBBVAs share capital reduction
19th May 20227:00 amRNSFinalization of acceptance period VTO for Garanti
17th May 20227:00 amRNSExecution of the buyback program
13th May 202212:30 pmRNS220513_BBVA_SBB Follow up Reporting
6th May 202210:32 amRNS220506_BBVA_SBB Follow up Reporting
3rd May 20227:00 amRNSSBB Follow up Reporting
29th Apr 20227:19 amRNS1Q22 Results Presentation
29th Apr 20227:19 amRNS1Q22 Results Press Release
29th Apr 20227:13 amRNS1Q22 Results Report
25th Apr 20227:00 amRNSIncrease of the Voluntary Takeover Bid for Garanti
22nd Apr 202210:09 amRNSBBVA_SBB Follow up Reporting
21st Apr 20223:32 pmRNS1Q22 Results Presentation Announcement
19th Apr 20227:00 amRNS220418_BBVA_SBB Follow up Reporting
8th Apr 202210:20 amRNSBBVA_SBB Follow up Reporting
6th Apr 20225:03 pmRNSEarly redemption AT1
1st Apr 202210:20 amRNS20220401_BBVA_SBB Follow up Reporting
31st Mar 20226:12 pmRNSApproved Information Memorandum VTO Garanti BBVA
24th Mar 202210:17 amRNS20220324_BBVA_SBB Follow up Reporting
18th Mar 20223:09 pmRNSResolutions AGM 2022
16th Mar 20227:00 amRNSInside information Buyback Program
11th Mar 20225:30 pmRNSBBVA Pillar 3 Report 2021
9th Mar 20227:00 amRNS2022 MREL Requirement
4th Mar 20227:00 amRNSSBB Follow up Reporting-1st Tranche End
1st Mar 202210:14 amRNS220301_BBVA_SBB Follow up Reporting
18th Feb 202210:29 amRNS220218_BBVA_SBB Follow up Reporting
15th Feb 20227:41 amRNS2022 AGM Proposed Resolutions
15th Feb 20227:38 amRNSApril dividend calendar
15th Feb 20227:37 amRNSIssuance of securities contingently convertible
14th Feb 20227:35 amRNSAgreement with Neon Payments Limited
11th Feb 20222:51 pmRNSStabilisation Notice
11th Feb 202210:24 amRNS220211_BBVA_SBB Follow up Reporting
10th Feb 20227:43 amRNS2022 Annual General Meeting Call
4th Feb 202210:25 amRNSPeriodic Report on the Buyback Program 20220204
3rd Feb 20227:12 amRNSSecond Tranche of the Share Buyback Program
3rd Feb 20227:10 amRNSShareholders' Remuneration
3rd Feb 20227:10 amRNSSREP Requirements
3rd Feb 20227:05 amRNS4Q21 Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.